PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 28400999-7 2017 Rapamycin and its analogues (rapalogues) bind to the intercellular receptor FKBP12, and then predominantly inhibit mTORC1 signaling via an allosteric mechanism. Sirolimus 0-9 FKBP prolyl isomerase 1A pseudogene 3 Homo sapiens 76-82 26314990-4 2016 Computational modeling confirmed that diffusion and binding constants of Corolimus and Sirolimus are identical and explained that the sustained retention of Corolimus was facilitated by binding to high affinity intracellular receptors (FKBP12). Sirolimus 87-96 FKBP prolyl isomerase 1A pseudogene 3 Homo sapiens 236-242 19351700-4 2009 The imaging utility of BRET3 at the single-cell level is demonstrated using an intramolecular sensor incorporating two mammalian target of rapamycin pathway proteins (FKBP12 and FRB) that dimerize only in the presence of rapamycin. Sirolimus 139-148 FKBP prolyl isomerase 1A pseudogene 3 Homo sapiens 167-173 23305836-4 2013 Although FKBP12 was first identified as the principal intracellular target for the immunosuppressive drugs, FK506 and rapamycin, new insights into the role of FKBPs have since emerged. Sirolimus 118-127 FKBP prolyl isomerase 1A pseudogene 3 Homo sapiens 9-15 9742506-1 1998 BACKGROUND: The 12 kD FK506 binding protein FKBP12 is a cytosolic receptor for the immunosuppressant drugs FK506 and rapamycin. Sirolimus 117-126 FKBP prolyl isomerase 1A pseudogene 3 Homo sapiens 44-50 17950843-7 2008 Under these conditions FK506, which displaces FKBP12 (to inhibit calcineurin) and rapamycin, which displaces FKBP12 (to inhibit mTOR), each increased the [Ca(2+)](c) rise evoked by caffeine. Sirolimus 82-91 FKBP prolyl isomerase 1A pseudogene 3 Homo sapiens 109-115 10361256-2 1999 The mechanism of this inhibition is investigated using FK506, which competes with rapamycin for binding to their common target FK506-binding protein (FKBP)12. Sirolimus 82-91 FKBP prolyl isomerase 1A pseudogene 3 Homo sapiens 150-157 7809080-3 1994 Using a two-hybrid system we isolated mammalian clones that interact with the human FK506/rapamycin-binding protein (FKBP12) in the presence of rapamycin. Sirolimus 90-99 FKBP prolyl isomerase 1A pseudogene 3 Homo sapiens 117-123 9434772-4 1997 Protein kinase activity directed towards mTOR was tightly associated with mTOR immunoprecipitates and this kinase activity was inhibited by FKBP12-rapamycin indicating it was due to an autokinase activity present in mTOR. Sirolimus 147-156 FKBP prolyl isomerase 1A pseudogene 3 Homo sapiens 140-146 8413204-2 1993 In Saccharomyces cerevisiae, rapamycin sensitivity is mediated by a specific cytoplasmic receptor which is a homolog of human FKBP12 (hFKBP12). Sirolimus 29-38 FKBP prolyl isomerase 1A pseudogene 3 Homo sapiens 126-132 8413204-2 1993 In Saccharomyces cerevisiae, rapamycin sensitivity is mediated by a specific cytoplasmic receptor which is a homolog of human FKBP12 (hFKBP12). Sirolimus 29-38 FKBP prolyl isomerase 1A pseudogene 3 Homo sapiens 134-141 8413204-3 1993 Deletion of the gene for yeast FKBP12 (RBP1) results in recessive drug resistance, and expression of hFKBP12 restores rapamycin sensitivity. Sirolimus 118-127 FKBP prolyl isomerase 1A pseudogene 3 Homo sapiens 101-108